Deep search
Rewards
Search
All
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
My Bing
Notebook
Top stories
U.S.
Local
World
Science
Technology
Entertainment
Business
Sports
More
Politics
Trending on Bing
PA Capitol bomb threat
Missing cruise teen found
49 drowned across Russia
Blames 'internet culture'
Brad Pitt's new 'F1' film
'Cross' sets premiere date
Job scams surge in 2023
Donors demand resignation
Mob ransacks CA mini-mart
Judge declines to dismiss suit
'Moana' in the works
Criticizes US-China chip war
11 killed in Nepal landslides
Frozen garbage on Everest
Body found in sleeping bag
Notches 1,000th career hit
Drops 'Not Like Us' video
Speaks at Essence Festival
Pays tribute to Jon Landau
NJ forest fire 65% contained
Rookie's historic game
Mars mission wraps up
NBA Summer League debut
NBA free agency 2024
Israelis push Gaza deal
Beats Artem Harutyunyan
RU wrestlers reject invitation
Actress Belushi-Pisano dies
Loses deals following arrest
Nate Diaz beats Masvidal
Hamas awaits ISR response
Lake fire grows: 12K acres
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
FDA, Alzheimer
FDA approves new early-stage Alzheimer's drug
According to the Alzheimer's Association, more than 129,000 people aged 65 and older have Alzheimer's disease in Tennessee.
FDA approves a new Alzheimer's drug. What to know about Eli Lilly's Kisunla
The FDA approved the experimental Alzheimer's drug donanemab. The drug will be sold under the brand name Kisunla.
FDA approves Eli Lilly Alzheimer’s drug after months of delay
The agency determined that the potential of slowing the devastating disease in patients with mild cognitive impairment outweigh the risks of brain bleeds.
WOOD Grand Rapids on MSN
6h
FDA approves another Alzheimer’s drug that can modestly slow disease
WASHINGTON (AP) — U.S. officials have
approved
another
Alzheimer’s
drug
that can modestly slow the disease, providing a ...
1d
on MSN
'It's a sad, sad disease': Local researchers work to bring new Alzheimer's drugs to patients
Doctors at the Roskamp Institute aim to treat around 10,000 patients a year with the new drugs and provide resources to area ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
Eli Lilly and Company
Kisunla
Feedback